Table 2.

Geriatric assessment and screening tools validated for use in Non-Hodgkin lymphoma patients.

Screening tool	Items	Time to administer	Correlation with outcomes
Simplified Geriatric Assessment (FIL)	ADL; IADL; Age; CIRS-G; IPI (EPI); Hemoglobin (EPI)	<10 min	Overall survival
ACA index and IADL- ACA	Age, Albumin (<3.7 g/dL), CCI IADL (IADL-ACA)	<10 min	Overall survival; Mean chemotherapy dose; Treatment toxicity and treatment-related mortality
Geriatric-8 (G8)	Nutritional Status; Polypharmacy; Age; Psychological Status; Health perception	<5 min	Overall Survival; Treatment toxicity
Vulnerable Elders Survey (VES-13)	Age; Self-rated health; Physical function; functional disabilities	<5 min	Overall Survival; Response rate
fTRST	Cognition; Living situation; Physical function; Polypharmacy	<5 min	Overall Survival; Treatment-related mortality
CRASH	Diastolic blood pressure; LDH; Functional status (IADL, Performance status); Nutritional status (MNA); Chemotherapy; Cognition (MMS)	<20 min	Treatment toxicity
CARG-TT	Age, Cancer type, Treatment, Hemoglobin, Kidney function, Physical function, IADL (medications), Falls, Hearing, Social activity	<5 min	Treatment toxicity*

FIL: Italian Lymphoma Foundation; ADL: Activities of daily living; IADL: Independent activities of daily living; CIRS-G – Cumulative Illness Rating Scale-Geriatric; IPI: International Prognostic Index; EPI: Elderly prognostic index; CCI: Charlson Comorbidity Index; ACA: Age, Comorbidities and Albumin Index; fTRST - Flemish version of the triage-screening tool; CRASH: Chemotherapy Risk Assessment Scale for High-Age Patients; MNA: Mini Nutritional Assessment; MMS: Mini Mental Scale; CARG-TT: Cancer Aging and Research Group toxicity tool.

^*Limited data in patients with NHL.